9
Inhibiting the SARS-CoV-2-PLpro enzyme is a novel avenue to explore in rational design of COVID-19 drugs, according to new research.
Inhibiting the SARS-CoV-2-PLpro enzyme is a novel avenue to explore in rational design of COVID-19 drugs, according to new research.